DNAPRINT GENOMICS INC (OTCMKTS:DNAG) reported an increase of 5.76% in shorted shares. FINRA announced in April DNAG’s total 5.32 million shorted shares. Previously was reported up change of 5.76% from 5.03M shares. Former DNAG’s position will need 94 days to restore. It has 56,800 average volume.
At traded at $0.0001 lastly.Since April 6, 2018 it’s 0.00% down thus . The stock underperformed the S&P500 by 4.37%.
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing services and products.The company has $64,460 market cap. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents.Currently it has negative earnings. The firm serves forensic science, genealogical research, consumer products, and pharmaceutical development clients.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.